Homart Pharmaceuticals Pty Ltd v Careline Australia Pty Ltd (No 2) [2017] FCA 769
It was not unreasonable for Homart to refuse the offer letter because the offer included a request to capitulate on the cross-claim, proposed packaging changes that were unclear and more proscriptive than the final orders, sought an apology and corrective advertising that were not sought or not granted, and contained uncertain terms. Those circumstances did not warrant indemnity costs.
- Jurisdiction
- Australia
- Judgment Date
- 21 June 2017
- Procedural Posture
- Application for Indemnity Costs / Costs Application After Final Orders
- Outcome
- Respondents' application for indemnity costs dismissed.
- Legal Topics
- ['indemnity Costs' 'without Prejudice Except as to Costs Offer' 'offer of Compromise' 'deceptively Similar Packaging' 'corrective Advertising']
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Procedural Posture
Application for Indemnity Costs / Costs Application After Final Orders
Legal Issues
- 1 ['Whether the Respondents should receive indemnity costs based on the offer in the letter dated 8 June 2016.' 'Whether it was unreasonable for Homart to refuse the offer letter.']
Ratio Decidendi
It was not unreasonable for Homart to refuse the offer letter because the offer included a request to capitulate on the cross-claim, proposed packaging changes that were unclear and more proscriptive than the final orders, sought an apology and corrective advertising that were not sought or not granted, and contained uncertain terms. Those circumstances did not warrant indemnity costs.
Court Disposition
Respondents' application for indemnity costs dismissed.
Orders
- ["The Respondents' application for costs payable on an indemnity basis be dismissed." "The Respondents pay the applicant's costs of the application for indemnity costs." 'The proceeding be listed for case management at 9.30 am on 12 July 2017.']
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment